PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3240 (106th)

Drug Import Fairness Act of 1999

referredUnited States· United States Congress· EN

Introduced

5 November 1999

Last action

—

Status

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsors

—

Subjects

Discovery layer

Source updated

3 June 2026

Official sourceDownload fileView documentsShare

Summary

Drug Import Fairness Act of 1999 - Amends the Federal Food, Drug, and Cosmetic Act (FDCA) to prohibit the Secretary of Health and Human Services, with regard to a drug being imported or offered for import, from sending a notice to a person suggesting that importing the drug is, or appears to be, in violation of the FDCA unless: (1) the Secretary determines the drug is adulterated, misbranded, in violation of FDCA provisions relating to new drugs, the drug is forbidden or restricted in sale in the producing or exporting country, importation by any person other than the manufacturer violates reimportation provisions, or the importation otherwise violates Federal law; (2) the notice does not specify any provision described in the provisions of this act relating to those determinations that is not applicable to the drug's importation; and (3) the notice states the underlying reasons for the determination.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

7 official files

Referred in Senate (text)

View fileDownload file

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.